ICD Code H35.3211

ICD code H35.3211 is a medical classification used to specify a diagnosis of exudative age-related macular degeneration in the right eye, characterized by active choroidal neovascularization. This condition involves the growth of new blood vessels in the choroid layer of the eye, which can lead to vision impairment or loss if not managed properly.

1. Presence of Exudative Age-Related Macular Degeneration (AMD): The patient must be diagnosed with exudative (wet) age-related macular degeneration, which is characterized by the abnormal growth of blood vessels under the retina and macula.

2. Involvement of the Right Eye: The condition specifically affects the right eye. It is crucial to identify the laterality to ensure accurate coding and treatment planning.

3. Active Choroidal Neovascularization (CNV): There must be evidence of active choroidal neovascularization, which involves the growth of new blood vessels originating from the choroid layer beneath the retina. This activity is typically confirmed through diagnostic imaging such as optical coherence tomography (OCT) or fluorescein angiography.

4. Symptoms of Vision Distortion or Loss: The patient may experience symptoms such as blurred vision, dark spots in the central vision, or distortion of straight lines, which are indicative of the progression of wet AMD.

5. Confirmation through Clinical Examination: A thorough eye examination by an ophthalmologist or optometrist is necessary to confirm the diagnosis, including the use of diagnostic tools to assess the presence and activity of CNV.

6. Exclusion of Other Retinal Conditions: Other potential causes of similar symptoms, such as diabetic retinopathy or retinal detachment, should be ruled out to ensure the accuracy of the diagnosis.

By adhering to these diagnostic criteria, healthcare providers can accurately utilize the ICD code for effective documentation and management of the condition.

For the ICD code H35.3211, which pertains to exudative age-related macular degeneration of the right eye with active choroidal neovascularization, the relevant CPT codes that may be applicable for treatment include:

1. 67028 - Intravitreal injection of a pharmacologic agent (e.g., anti-VEGF therapy).

2. 67210 - Destruction of localized lesion of retina (e.g., photocoagulation).

3. 67221 - Destruction of extensive or progressive retinopathy (e.g., photodynamic therapy with verteporfin).

These CPT codes are commonly used in procedures aimed at managing and treating conditions associated with this specific ICD code. It's important for healthcare providers to ensure accurate coding to facilitate proper billing and reimbursement processes.

Discover how MD Clarity's RevFind software can enhance your revenue cycle management by accurately reading your contracts and detecting underpayments for CPT codes associated with ICD codes, such as H35.3211. Schedule a demo today to see how RevFind can help ensure you're receiving the full reimbursement you deserve.